INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

DTILPRECISION BIOSCIENCES INC

CIK 0001357874

EDGAR filingsOpen in network
Disclosed transactions29
Buys / sells1 / 4
Max Insider Score29
Connections6with evidence

DTIL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
FS
Frankel StanleyDirector
DTILPRECISION BIOSCIENCES INC
Open-market purchase
BUY$6,000
1,000 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Frankel StanleyDirector · Sep 30, 2026
  • ← Insider ofevidence
    Amoroso MichaelDirector, President and CEO · Jan 22, 2026
  • ← Insider ofevidence
    Scimeca DarioGeneral Counsel and Secretary · Jan 22, 2026
3
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M
—
8,888 sh
Jan 20, 2026
Jan 22, 2026
traded Jan 20, 2026
+2d
SEC FORM 4

Evidence

7
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
37.1K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

7
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
69.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

27
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$145K
34.8K sh
Jan 22, 2026Jan 22, 2026
traded Jan 22, 2026
+0dSEC FORM 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
37.1K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
69.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

3
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
1,978 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

7
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,425 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

7
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
14.9K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

24
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$36K
8,854 sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC FORM 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
1,978 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,425 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
14.9K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

3
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

3
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
13.9K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

7
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
26.6K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

27
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$61K
15.2K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC FORM 4

Evidence

0
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

11
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
13.9K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
26.6K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

3
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
10.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

3
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
16.2K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC FORM 4

Evidence

24
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$41K
10.2K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC FORM 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
10.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
16.2K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Kelly John AlexanderChief Financial Officer · Jan 22, 2026
  • ← Insider ofevidence
    Smith J. JeffersonChief Research Officer · Jan 22, 2026